DK Medical: what changed
DK Medical
Largest movements
- Receivables within one year +€109,140
up €109,140 (+267%), from €40,817 to €149,958
of which Trade receivables: +€97,421
- Cash +€57,982
up €57,982 (+13.9%), from €417,696 to €475,679
mainly Net result for the year (+€186,064) and Advances received (+€57,982)
- Stocks and contracts +€49,826
up €49,826 (+105%), from €47,584 to €97,410
- Tangible fixed assets -€28,980
down €28,980 (-51.4%), from €56,345 to €27,365
of which Leasing and similar rights: -€28,873
- Reserves +€145,813
up €145,813 (+44.9%), from €324,417 to €470,230
- Advances received +€57,982
up €57,982 (+430%), from €13,492 to €71,474
- Tax, wage and social debts +€19,780
up €19,780 (+24.3%), from €81,268 to €101,047
of which Taxes: +€19,504
- Debts after one year -€19,544
down €19,544 (-100%), from €19,544 to €0
- Current portion of long-term debt -€9,141
down €9,141 (-31.9%), from €28,685 to €19,544
- Depreciation -€6,356
down €6,356 (-16.7%), from €38,078 to €31,722
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €570,097 | €758,060 | +€187,963 | +33.0% |
| Fixed assets | 21/28 | €56,345 | €27,365 | -€28,980 | -51.4% |
| Tangible fixed assets | 22/27 | €56,345 | €27,365 | -€28,980 | -51.4% |
| Furniture and vehicles | 24 | - | €1,912 | +€1,912 | |
| Leasing and similar rights | 25 | €48,366 | €19,493 | -€28,873 | -59.7% |
| Other tangible fixed assets | 26 | €7,980 | €5,960 | -€2,019 | -25.3% |
| Current assets | 29/58 | €513,752 | €730,695 | +€216,943 | +42.2% |
| Stocks and contracts in progress | 3 | €47,584 | €97,410 | +€49,826 | +105% |
| Stocks | 30/36 | €47,584 | €97,410 | +€49,826 | +105% |
| Amounts receivable within one year | 40/41 | €40,817 | €149,958 | +€109,140 | +267% |
| Trade receivables | 40 | €40,817 | €138,238 | +€97,421 | +239% |
| Other amounts receivable | 41 | €0 | €11,719 | +€11,719 | |
| Cash at bank and in hand | 54/58 | €417,696 | €475,679 | +€57,982 | +13.9% |
| Deferred charges and accrued income | 490/1 | €7,653 | €7,649 | -€5 | -0.1% |
| Total equity and liabilities | 10/49 | €570,097 | €758,060 | +€187,963 | +33.0% |
| Equity | 10/15 | €330,617 | €476,430 | +€145,813 | +44.1% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €324,417 | €470,230 | +€145,813 | +44.9% |
| Distributable reserves | 133 | €324,417 | €470,230 | +€145,813 | +44.9% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €239,480 | €281,630 | +€42,150 | +17.6% |
| Amounts payable after more than one year | 17 | €19,544 | €0 | -€19,544 | -100% |
| Financial debts | 170/4 | €19,544 | €0 | -€19,544 | -100% |
| Amounts payable within one year | 42/48 | €204,514 | €270,368 | +€65,854 | +32.2% |
| Current portion of amounts payable after more than one year | 42 | €28,685 | €19,544 | -€9,141 | -31.9% |
| Trade debts | 44 | €31,485 | €36,058 | +€4,574 | +14.5% |
| Suppliers | 440/4 | €31,485 | €36,058 | +€4,574 | +14.5% |
| Advances received on contracts in progress | 46 | €13,492 | €71,474 | +€57,982 | +430% |
| Taxes, remuneration and social security | 45 | €81,268 | €101,047 | +€19,780 | +24.3% |
| Taxes | 450/3 | €57,352 | €76,856 | +€19,504 | +34.0% |
| Remuneration and social security | 454/9 | €23,916 | €24,192 | +€276 | +1.2% |
| Other amounts payable | 47/48 | €49,584 | €42,244 | -€7,340 | -14.8% |
| Accrued charges and deferred income | 492/3 | €15,421 | €11,262 | -€4,160 | -27.0% |
| Remuneration, social security and pensions | 62 | €204,820 | €205,443 | +€623 | +0.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,078 | €31,722 | -€6,356 | -16.7% |
| Other operating charges | 640/8 | €5,784 | €5,184 | -€600 | -10.4% |
| Gross operating margin | 9900 | €514,640 | €511,221 | -€3,419 | -0.7% |
| Operating profit (loss) | 9901 | €265,957 | €268,872 | +€2,915 | +1.1% |
| Financial income | 75/76B | €667 | €1,744 | +€1,077 | +162% |
| Recurring financial income | 75 | €667 | €1,744 | +€1,077 | +162% |
| Financial charges | 65/66B | €1,392 | €854 | -€538 | -38.6% |
| Recurring financial charges | 65 | €1,392 | €854 | -€538 | -38.6% |
| Profit (loss) for the period before taxes | 9903 | €265,231 | €269,761 | +€4,530 | +1.7% |
| Income taxes | 67/77 | €82,342 | €83,698 | +€1,355 | +1.6% |
| Profit (loss) for the period | 9904 | €182,889 | €186,064 | +€3,174 | +1.7% |
| Profit (loss) for the period to be appropriated | 9905 | €182,889 | €186,064 | +€3,174 | +1.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.